New Stock Coverage: Fate Therapeutics Leaves Nothing to Chance


Today is an especially ominous anniversary on Wall Street , October has had more than its fair share of stock market horror stories, and Halloween is almost here. Yet fat cats continue to win out over 'fraidy cats. With Spain, land of the matador, officially out of recession , the bull is proving terribly tough to kill. Kill Bill? Not if you are birthday boy Mr. Gates, 58 today, who just bet big on Iberia himself and saw his Microsoft ( MSFT ) surge 5.96% to top all Dow (INDEXDJX:.DJI) issues on Friday. Over at fellow blue chip Procter & Gamble ( PG ), CEO A.G. Lafley is skipping conference calls , a Teutonic shift likely inspired by the telephone travails of Ms. Merkel . Telecom titan AT&T Inc. ( T ), whose net income rose 5% to $3.91 billion, needn't have any hang-ups, however. Especially after Kanye West proposed to Kim Kardashian in typically understated fashion on the jumbotron at San Francisco's AT&T Park. (Here's the happy couple .)

This morning in economic data, September pending home sales are due at 10:00 a.m. Eastern. On the corporate front, just under half of the S&P 500 Index (INDEXSP:.INX) have now released quarterly results. Today's announcements are expected to include América Móvil ( AMX ), Apple ( AAPL ), Biogen Idec (BIIB), Herbalife (HLF), Linn Energy (LINE), Loews Corporation (L), Masco (MAS), Merck (MRK), Riverbed Technology (RVBD), Seagate Technology (STX), and TNT Express (OTCMKTS:TNTEY).

Fate Therapeutics (FATE): The biotech, an insider favorite , is begun with bullish Outperforms by BMO Capital, Cowen, and Wedbush ($14 price objective.) The company's principal product, ProHema for hematopoietic stem cell transplantation (HSCT), shows promise.

Gigamon (GIMO): GIMO gets initiated with an Outperform at William Blair.

HomeAway (AWAY): Cowen covers the stock at Outperform.

International Game Technology (IGT): Citigroup starts the maker of casino games at a Buy.

RE/MAX Holdings (RMAX): Calling the company a way to play an ongoing US housing recovery, RBC Capital resumes Outperform-rated research. Its price objective is $33.

Ruckus Wireless (RKUS): Northland Capital has a new Market Perform rating, and $18 target price, on the stock.

SolarCity (SCTY): The alternative energy name is assigned an Outperform at Credit Suisse.

(See also: Stock Upgrades: AstraZeneca Has It Covered From A to Z and Stock Downgrades: Crocs Takes a Walk on the Wild Side )

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

This article appears in: Investing , Stocks

Referenced Stocks: AAPL , AMX , MSFT , PG , T



More from Minyanville:

Related Videos



Most Active by Volume

  • $16.44 ▲ 2.37%
  • $10.19 ▲ 28.66%
  • $112.92 ▲ 2.94%
  • $25.01 ▲ 4.16%
  • $105.64 ▲ 2.53%
  • $2.28 ▲ 49.02%
  • $27.99 ▼ 2.34%
  • $43.90 ▲ 2.79%
As of 8/27/2015, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by